The future of biomedical research is animal-free

As a scientist focused on tangible data and results, it’s easy to be sceptical about the impact of legislative acts: the path from Congress to the lab is long and winding. Despite the subtle change and lack of immediate impact on patients, the FDA Modernization Act 2.0 is anything but inconsequential. I think, in truth, that it may be the spark needed to ignite the next era of animal-free drug…

Comments Off on The future of biomedical research is animal-free

Podcast: Building Careers in Biotech

"As a PhD, you're very focused on the question and the process of how you get things done. Our focus [as a Biotech company] is on what impact we want to have, where we're going and the key questions that our partners are trying to answer." Samantha Dale Strasser is the Chief Scientific Officer of Pepper Bio, the world's first transomic analysis company. Samantha joined us in a fascinating discussion…

Comments Off on Podcast: Building Careers in Biotech

Breast Cancer By A New Name: Redefining Disease For Better Patient Outcomes

Everyone knows someone with cancer, so this question may be confusing, but: Does anyone have cancer anymore? What I mean is: At first, there was cancer. Now, there is chronic myeloid leukemia and acute lymphocytic leukemia; primary colorectal lymphomas and gastrointestinal stromal tumors; and six subgroups of triple-negative breast cancer. We’ve outgrown the blanket term “cancer,” and it’s making a positive difference in how we treat and overcome disease. In…

Comments Off on Breast Cancer By A New Name: Redefining Disease For Better Patient Outcomes

The Problems We Must Overcome Before A Patient Enters Their Doctor’s Office

I had my first migraine in middle school. Over a decade later, I was prescribed a cocktail of drugs—my saving grace. I could finally take hold of my life, and I no longer held on to an ever-present worry that my migraines could steal days of my time and derail what I was working toward. I had an ideal experience: Diagnosis was possible, treatment was possible, and my response was…

Comments Off on The Problems We Must Overcome Before A Patient Enters Their Doctor’s Office

Podcast: In Conversation with Simon Fricker

DDW’s Megan Thomas is in conversation with Dr Simon Fricker, who just last year was made Chief Development Officer of PepperBio to support the company’s next phase of growth and guide the strategic expansion of Pepper’s oncology pipeline. Over the course of his career, including eight years as a distinguished scientific fellow at Genzyme/Sanofi, Dr Fricker worked on three approved drugs: Paraplatin, Fosrenol, and Mozobil. Dr. Fricker was a founder of…

Comments Off on Podcast: In Conversation with Simon Fricker

Q&A with Pepper Bio Senior Computational Biologist, Sam Roth

Please welcome the newest member of the Pepper Bio team, Sam Roth! Sam joins us from a role at Fulcrum Therapeutics, where he focused on developing computational methods for analyzing NGS data with the aim of target discovery in rare genetic disease. Sam’s first day at Pepper as a Senior Computational Biologist was just over a week ago. You can learn more about why Sam joined our team, as well…

Comments Off on Q&A with Pepper Bio Senior Computational Biologist, Sam Roth